Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
68,794
Employees68,794
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
68,794
Employees68,794

NVO Key Statistics

Market cap
186.64B
Market cap186.64B
Price-Earnings ratio
10.38
Price-Earnings ratio10.38
Dividend yield
2.89%
Dividend yield2.89%
Average volume
9.02M
Average volume9.02M
High today
$43.23
High today$43.23
Low today
$41.89
Low today$41.89
Open price
$42.46
Open price$42.46
Volume
5.94M
Volume5.94M
52 Week high
$64.16
52 Week high$64.16
52 Week low
$35.12
52 Week low$35.12

NVO News

Nasdaq 39m
Where Will Novo Nordisk Be in 5 Years as the GLP-1 Market Gets More Crowded?

Key Points Novo Nordisk has lost its lead in the weight loss market. The company could face even more competition going forward. However, its deep pipeline s...

Where Will Novo Nordisk Be in 5 Years as the GLP-1 Market Gets More Crowded?
Benzinga 2h
Novo Nordisk, Anthropic Team Up For AI Drug Research

Novo Nordisk A/S (NYSE:NVO) announced a collaboration with Anthropic that it says will help accelerate the development of new medicines. The companies will joi...

Novo Nordisk, Anthropic Team Up For AI Drug Research
TipRanks 2h
Novo Partners with Anthropic on AI Drug Discoveries

Danish pharmaceutical giant Novo (NVO) is partnering with startup Anthropic to advance drug discoveries using artificial intelligence (AI) technologies. In a st...

More NVO News

The Wall Street Journal 4h
Novo Partners With Anthropic to Speed Up Drug Discovery Using Claude

Novo Nordisk and Anthropic are teaming up to deploy the Claude artificial-intelligence model. Chris Ratcliffe / Bloomberg News Novo Nordisk NOVO.B 0.54 %increa...

Novo Partners With Anthropic to Speed Up Drug Discovery Using Claude
TipRanks 5h
Novo Nordisk announces collaboration with Anthropic

The company states: “Novo Nordisk (NVO) and Anthropic announced a collaboration that will help Novo accelerate the development of new medicines and advance AI-d...

Simply Wall St 9h
Ascendis Pharma Reclaims Global TransCon Rights For Obesity And Heart Disease

Ascendis Pharma (NasdaqGS:ASND) has regained global rights to its TransCon technology in metabolic and cardiovascular diseases after ending its collaboration wi...

Ascendis Pharma Reclaims Global TransCon Rights For Obesity And Heart Disease
Simply Wall St 22h
Novo Nordisk Unveils Novo Rebrand And The Novo Way Reset

Novo Nordisk (NYSE:NVO) is rebranding globally to the shorter corporate name Novo as part of a broad identity shift. The group is rolling out a refreshed cultu...

Novo Nordisk Unveils Novo Rebrand And The Novo Way Reset
24/7 Wall St. 1d
Novo Nordisk Expands Obesity Drug to Children, But Market Hesitates on Adoption

Investing Novo Nordisk Expands Obesity Drug to Children, But Market Hesitates on Adoption A landmark trial just proved semaglutide can pull children as young as...

Novo Nordisk Expands Obesity Drug to Children, But Market Hesitates on Adoption
Nasdaq 1d
Novo Nordisk vs. Regeneron Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?

Key Points Novo Nordisk continues to dominate the global diabetes and obesity care markets with its portfolio of blockbuster GLP-1 therapies. Regeneron Pharma...

Novo Nordisk vs. Regeneron Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
TipRanks 1d
Novo Nordisk Stock Is Falling Despite Rebrand to ‘Novo’ — Here’s Why

Novo Nordisk shares (NVO) fell by 1% to around $43 per share early Tuesday. This came even after the popular obesity drugmaker rebranded simply to “Novo” on Mon...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.